Hormonal
Testosterone therapy improves erectile function and libido in men with documented testosterone deficiency, and may have synergistic effects when combined with phosphodiesterase-5 inhibitors in those who do not respond to either treatment alone.
If you are struggling with low sex drive or erectile dysfunction, ask your doctor to check your testosterone levels. If they are low, testosterone therapy can help. If you are already taking medication for ED (like Viagra) and it isn't working well, adding testosterone might improve the effect. Always discuss all your symptoms with your doctor.
Men with ED and/or diminished libido and documented testosterone deficiency are candidates for testosterone therapy... There is evidence suggesting therapeutic synergism with combined use of testosterone and phosphodiesterase-5 inhibitors in hypogonadal or borderline eugonadal men
Why this rating
Based on Level 2a evidence for TRT efficacy and Level 1b for combination therapy.
Source
Investigation, Treatment, and Monitoring of Late‐Onset Hypogonadism in Males: ISA, ISSAM, EAU, EAA, and ASA Recommendations
C. Wang et al. · Journal of Andrology · 2008
DOI 10.2164/jandrol.108.006486
More from this paper
- Testosterone replacement therapy in older men with confirmed late-onset hypogonadism improves body composition by decreasing fat mass and increasing lean body mass.Limited
- Testosterone therapy does not increase the risk of prostate cancer or benign prostatic hyperplasia (BPH) in men without existing prostate disease, but it can aggravate symptoms in men with locally advanced or metastatic prostate cancer.Limited
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →